Clinical Trials Browser

Interventional × Advanced Solid Tumors × Erlotinib Hydrochloride × Clear all

NCT02057380 2024-11-20

A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

Phase 2 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT00139620 2018-02-08

A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors